vs

Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Brown–Forman (BF.B). Click either name above to swap in a different company.

Brown–Forman is the larger business by last-quarter revenue ($1.0B vs $962.7M, roughly 1.1× APTARGROUP, INC.). Brown–Forman runs the higher net margin — 21.6% vs 7.7%, a 13.9% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs -5.4%). Brown–Forman produced more free cash flow last quarter ($107.0M vs $96.9M). Over the past eight quarters, APTARGROUP, INC.'s revenue compounded faster (2.6% CAGR vs -1.6%).

AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.

Brown-Forman Corporation is an American family-controlled publicly traded company, one of the largest in the spirits and wine business. Based in Louisville, Kentucky, it manufactures several very well known brands throughout the world, including Jack Daniel's, Old Forester, Woodford Reserve, GlenDronach, BenRiach, Glenglassaugh, Herradura, Korbel, and Chambord. Brown-Forman formerly owned Southern Comfort and Tuaca before selling them off in 2016.

ATR vs BF.B — Head-to-Head

Bigger by revenue
BF.B
BF.B
1.1× larger
BF.B
$1.0B
$962.7M
ATR
Growing faster (revenue YoY)
ATR
ATR
+18.9% gap
ATR
13.5%
-5.4%
BF.B
Higher net margin
BF.B
BF.B
13.9% more per $
BF.B
21.6%
7.7%
ATR
More free cash flow
BF.B
BF.B
$10.1M more FCF
BF.B
$107.0M
$96.9M
ATR
Faster 2-yr revenue CAGR
ATR
ATR
Annualised
ATR
2.6%
-1.6%
BF.B

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ATR
ATR
BF.B
BF.B
Revenue
$962.7M
$1.0B
Net Profit
$74.3M
$224.0M
Gross Margin
59.4%
Operating Margin
11.0%
29.4%
Net Margin
7.7%
21.6%
Revenue YoY
13.5%
-5.4%
Net Profit YoY
-26.4%
-13.2%
EPS (diluted)
$1.13
$0.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATR
ATR
BF.B
BF.B
Q4 25
$962.7M
$1.0B
Q3 25
$961.1M
$924.0M
Q2 25
$966.0M
$894.0M
Q1 25
$887.3M
$1.0B
Q4 24
$848.1M
$1.1B
Q3 24
$909.3M
$951.0M
Q2 24
$910.1M
$964.0M
Q1 24
$915.4M
$1.1B
Net Profit
ATR
ATR
BF.B
BF.B
Q4 25
$74.3M
$224.0M
Q3 25
$127.9M
$170.0M
Q2 25
$111.7M
$146.0M
Q1 25
$78.8M
$270.0M
Q4 24
$100.9M
$258.0M
Q3 24
$100.0M
$195.0M
Q2 24
$90.5M
$266.0M
Q1 24
$83.1M
$285.0M
Gross Margin
ATR
ATR
BF.B
BF.B
Q4 25
59.4%
Q3 25
59.7%
Q2 25
57.4%
Q1 25
59.8%
Q4 24
59.0%
Q3 24
59.4%
Q2 24
59.0%
Q1 24
59.4%
Operating Margin
ATR
ATR
BF.B
BF.B
Q4 25
11.0%
29.4%
Q3 25
14.2%
28.1%
Q2 25
14.9%
22.9%
Q1 25
12.8%
27.1%
Q4 24
14.2%
31.1%
Q3 24
15.2%
29.5%
Q2 24
13.8%
38.9%
Q1 24
12.2%
34.9%
Net Margin
ATR
ATR
BF.B
BF.B
Q4 25
7.7%
21.6%
Q3 25
13.3%
18.4%
Q2 25
11.6%
16.3%
Q1 25
8.9%
26.1%
Q4 24
11.9%
23.6%
Q3 24
11.0%
20.5%
Q2 24
9.9%
27.6%
Q1 24
9.1%
26.7%
EPS (diluted)
ATR
ATR
BF.B
BF.B
Q4 25
$1.13
$0.47
Q3 25
$1.92
$0.36
Q2 25
$1.67
$0.31
Q1 25
$1.17
$0.57
Q4 24
$1.48
$0.55
Q3 24
$1.48
$0.41
Q2 24
$1.34
$0.56
Q1 24
$1.23
$0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATR
ATR
BF.B
BF.B
Cash + ST InvestmentsLiquidity on hand
$409.5M
$319.0M
Total DebtLower is stronger
$1.1B
$2.4B
Stockholders' EquityBook value
$2.7B
$4.1B
Total Assets
$5.3B
$8.2B
Debt / EquityLower = less leverage
0.43×
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATR
ATR
BF.B
BF.B
Q4 25
$409.5M
$319.0M
Q3 25
$264.8M
$471.0M
Q2 25
$169.8M
$444.0M
Q1 25
$136.8M
$599.0M
Q4 24
$226.2M
$416.0M
Q3 24
$327.9M
$416.0M
Q2 24
$223.9M
$446.0M
Q1 24
$201.1M
$589.0M
Total Debt
ATR
ATR
BF.B
BF.B
Q4 25
$1.1B
$2.4B
Q3 25
$546.0M
$2.4B
Q2 25
$535.1M
$2.4B
Q1 25
$561.2M
$2.7B
Q4 24
$688.1M
$2.7B
Q3 24
$822.7M
$2.7B
Q2 24
$681.5M
$2.7B
Q1 24
$680.4M
$2.7B
Stockholders' Equity
ATR
ATR
BF.B
BF.B
Q4 25
$2.7B
$4.1B
Q3 25
$2.8B
$4.0B
Q2 25
$2.7B
$4.0B
Q1 25
$2.5B
$3.8B
Q4 24
$2.5B
$3.7B
Q3 24
$2.5B
$3.5B
Q2 24
$2.4B
$3.5B
Q1 24
$2.3B
$3.2B
Total Assets
ATR
ATR
BF.B
BF.B
Q4 25
$5.3B
$8.2B
Q3 25
$5.1B
$8.2B
Q2 25
$4.9B
$8.1B
Q1 25
$4.5B
$8.1B
Q4 24
$4.4B
$8.3B
Q3 24
$4.6B
$8.2B
Q2 24
$4.5B
$8.2B
Q1 24
$4.4B
$8.2B
Debt / Equity
ATR
ATR
BF.B
BF.B
Q4 25
0.43×
0.59×
Q3 25
0.20×
0.61×
Q2 25
0.20×
0.61×
Q1 25
0.22×
0.70×
Q4 24
0.28×
0.73×
Q3 24
0.32×
0.77×
Q2 24
0.28×
0.76×
Q1 24
0.29×
0.83×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATR
ATR
BF.B
BF.B
Operating Cash FlowLast quarter
$183.7M
$132.0M
Free Cash FlowOCF − Capex
$96.9M
$107.0M
FCF MarginFCF / Revenue
10.1%
10.3%
Capex IntensityCapex / Revenue
9.0%
2.4%
Cash ConversionOCF / Net Profit
2.47×
0.59×
TTM Free Cash FlowTrailing 4 quarters
$299.6M
$610.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATR
ATR
BF.B
BF.B
Q4 25
$183.7M
$132.0M
Q3 25
$177.6M
$160.0M
Q2 25
$126.0M
$152.0M
Q1 25
$82.7M
$317.0M
Q4 24
$178.2M
$112.0M
Q3 24
$229.3M
$17.0M
Q2 24
$143.6M
$285.0M
Q1 24
$92.3M
$265.0M
Free Cash Flow
ATR
ATR
BF.B
BF.B
Q4 25
$96.9M
$107.0M
Q3 25
$114.3M
$129.0M
Q2 25
$62.5M
$102.0M
Q1 25
$25.9M
$272.0M
Q4 24
$112.2M
$81.0M
Q3 24
$162.7M
$-24.0M
Q2 24
$75.4M
$205.0M
Q1 24
$16.7M
$196.0M
FCF Margin
ATR
ATR
BF.B
BF.B
Q4 25
10.1%
10.3%
Q3 25
11.9%
14.0%
Q2 25
6.5%
11.4%
Q1 25
2.9%
26.3%
Q4 24
13.2%
7.4%
Q3 24
17.9%
-2.5%
Q2 24
8.3%
21.3%
Q1 24
1.8%
18.3%
Capex Intensity
ATR
ATR
BF.B
BF.B
Q4 25
9.0%
2.4%
Q3 25
6.6%
3.4%
Q2 25
6.6%
5.6%
Q1 25
6.4%
4.3%
Q4 24
7.8%
2.8%
Q3 24
7.3%
4.3%
Q2 24
7.5%
8.3%
Q1 24
8.3%
6.5%
Cash Conversion
ATR
ATR
BF.B
BF.B
Q4 25
2.47×
0.59×
Q3 25
1.39×
0.94×
Q2 25
1.13×
1.04×
Q1 25
1.05×
1.17×
Q4 24
1.77×
0.43×
Q3 24
2.29×
0.09×
Q2 24
1.59×
1.07×
Q1 24
1.11×
0.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATR
ATR

Pharma Segment$833.1M87%
Other$129.6M13%

BF.B
BF.B

Whiskey$771.0M74%
Ready To Drink$138.0M13%
Tequila$67.0M6%
Restofportfolio$52.0M5%
Nonbrandedandbulk$8.0M1%

Related Comparisons